Plavix "Irreparable Harm" Debated During Preliminary Injunction Appeal
This article was originally published in The Pink Sheet Daily
Executive Summary
Patent litigation case between Sanofi/Bristol and Apotex will follow in January.
You may also be interested in...
Sanofi/Bristol Score Another Victory Over Apotex In Plavix Dispute
Generic drug maker is thwarted in latest attempt to resume clopidogrel sales.
Sanofi/Bristol Score Another Victory Over Apotex In Plavix Dispute
Generic drug maker is thwarted in latest attempt to resume clopidogrel sales.
Generic Plavix Supply Is Dwindling, McKesson Says
Wholesaler forecasts little additional sales of clopidogrel through the remainder of the year.